Current and Potential Use of Biologically Active Compounds Derived from Cannabis sativa L. in the Treatment of Selected Diseases
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(23), P. 12738 - 12738
Published: Nov. 27, 2024
Cannabis
sativa
L.
contains
numerous
compounds
with
antioxidant
and
anti-inflammatory
properties,
including
the
flavonoids
cannabinoids,
particularly
Δ-9-tetrahydrocannabinol
(THC)
cannabidiol
(CBD).
Cannabinoids
have
an
effect
on
endocannabinoid
system
(ECS),
a
cellular
communication
network,
are,
hence,
widely
studied
for
medical
applications.
Epidiolex®,
99%
pure
oral
CBD
extract,
has
been
approved
by
FDA
treatment
of
epilepsy.
Nabiximols
(Sativex)
is
oromucosal
spray
containing
equal
volume
THC
CBD,
it
commonly
used
as
add-on
unresponsive
spasticity
in
multiple
sclerosis
(MS)
patients.
Several
vitro
vivo
studies
also
shown
that
cannabinoids
can
be
to
treat
various
types
cancer,
such
melanoma
brain
glioblastoma;
first
positive
clinical
trials
anticancer
THC:CBD
blend
temozolomide
(TMZ)
highly
invasive
cancer
are
very
promising.
The
exert
their
properties
investigations
induction
cell
death,
mainly
apoptosis
cytotoxic
autophagy,
inhibition
proliferation.
In
several
studies,
found
induce
tumor
regression
inhibit
angiogenic
mechanisms
vivo,
well
two
low-numbered
epidemiological
studies.
They
exhibit
antiviral
effects
inhibiting
ACE2
transcription,
blocking
viral
replication
fusion,
acting
agents;
indeed,
prior
consumption
(a
study
93,565
persons
Chicago)
associated
much
lower
incidence
SARS-CoV-2
infections.
It
postulated
cannabis
extracts
many
other
diseases
systemic
lupus
erythematosus,
type
1
diabetes,
or
neurological
disorders,
e.g.,
Alzheimer’s
disease.
aim
this
review
outline
current
state
knowledge
regarding
currently
medicinal
preparations
derived
from
C.
selected
diseases,
present
latest
research
potential
applications
its
secondary
metabolites.
Language: Английский
Cannabinoids as Promising Inhibitors of HER2-Tyrosine Kinase: A Novel Strategy for Targeting HER2-Positive Ovarian Cancer
Thomanai Lamtha,
No information about this author
Nathjanan Jongkon,
No information about this author
Tossaporn Lertvanithphol
No information about this author
et al.
ACS Omega,
Journal Year:
2025,
Volume and Issue:
10(6), P. 6191 - 6200
Published: Feb. 8, 2025
Human
epidermal
growth
factor
receptor
2
(HER2)
is
a
transmembrane
within
the
ErbB
family
that
plays
pivotal
role
in
progression
of
various
aggressive
cancers.
HER2-positive
tumors
often
develop
resistance
to
standard
therapies,
necessitating
exploration
innovative
treatment
options.
Cannabinoids,
bioactive
compounds
from
Cannabis
sativa
such
as
cannabidiol
(CBD),
cannabigerol
(CBG),
and
cannabinol
(CBN),
have
gained
attention
for
their
potential
anticancer
properties.
This
study
evaluates
efficacy
CBD,
CBG,
CBN
targeting
ovarian
cancer
through
kinase
inhibition
assays,
surface
plasmon
resonance
(SPR),
molecular
docking,
cell
viability
assessments.
SPR
analysis
revealed
cannabinoids
bind
strongly
HER2-tyrosine
(HER2-TK),
with
CBD
showing
highest
affinity
(K
D
=
6.16
μM),
significantly
better
than
afatinib
26.30
CBG
demonstrating
moderate
17.07
μM).
In
was
most
potent
inhibitor
(IC50
24.7
nM),
followed
by
38
suggesting
ability
disrupt
HER2-mediated
signaling
pathways.
Molecular
docking
studies
highlighted
critical
interactions
between
essential
HER2
residues
(Leu796,
Thr862,
Asp863).
effectively
inhibited
SKOV3
cells
13.8
μM
16.6
μM,
respectively),
comparable
traditional
tyrosine
inhibitors.
These
findings
underscore
therapeutic
cannabinoids,
particularly
alternative
or
adjunct
therapies
cancers,
promise
mitigating
adverse
effects
associated
existing
treatments.
Language: Английский
Research mapping of cannabinoids and endocannabinoid system in cancer over the past three decades: insights from bibliometric analysis
Yaqian Tan,
No information about this author
Hui Xia,
No information about this author
Qi Song
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 2, 2025
Background
The
cannabinoids
and
endocannabinoid
system
are
thought
to
play
critical
roles
in
multiple
signaling
pathways
organisms,
extensive
evidence
from
preclinical
studies
indicated
that
endocannabinoids
displayed
anticancer
potential.
This
study
aimed
summarize
the
research
of
cancer
through
bibliometric
analysis.
Methods
Relevant
literature
field
published
during
1995–2024
were
collected
Web
Science
Core
Collection
database.
VOSviewer
SCImago
Graphica
applied
perform
analysis
countries,
institutions,
authors,
journals,
documents,
keywords.
Results
A
total
3,052
publications
identified,
global
output
exhibited
a
generally
upward
trend
over
past
3
decades.
USA
had
greatest
number
citations
this
field.
Italian
National
Research
Council
led
terms
publication,
while
Complutense
University
Madrid
highest
citations.
Vincenzo
Di
Marzo
was
leading
author
with
co-occurrence
keywords
revealed
frontiers
mainly
included
“cannabinoids”,
“endocannabinoid
system”,
“cancer”,
“anandamide”,
“cannabidiol”,
“cannabinoid
receptor”,
“apoptosis”,
“proliferation”.
Conclusion
Our
results
would
receive
continuous
attention.
Italy
have
made
remarkable
contributions
field,
supported
by
their
influential
institutions
prolific
scholars.
emphasis
has
evolved
basic
functional
characterization
mechanistic
exploration
disease
translational
applications
within
multidisciplinary
framework.
Language: Английский
Cannabidiol as a novel therapeutic agent in breast cancer: evidence from literature
BMC Cancer,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: April 24, 2025
Language: Английский
THE MULTIPLE APPLICATIONS OF INDUSTRIAL HEMP (CANNABIS SATIVA L.) IN THE CONTEXT OF SUSTAINABLE DEVELOPMENT
Lorena-Diana POPA,
No information about this author
Simona-Florina Isticioaia,
No information about this author
V. Vlăduț
No information about this author
et al.
INMATEH Agricultural Engineering,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1051 - 1071
Published: April 30, 2025
This
review
explores
the
multiple
directions
of
industrial
hemp
(Cannabis
sativa
L.)
utilization
at
a
global
level,
highlighting
importance
this
crop
as
renewable,
sustainable,
and
environmentally
friendly
resource.
While
has
traditionally
been
employed
for
production
fibers,
seeds,
medicinal
products,
recent
studies
have
expanded
its
applications
into
innovative
fields
such
eco-friendly
construction
materials
(e.g.,
hempcrete
composite
materials),
automotive
aerospace
industries,
cosmetics,
biofuels,
others.
The
remarkable
properties
hemp,
including
low
density,
superior
mechanical
strength,
carbon
sequestration
capability,
moisture
regulation,
help
reduce
energy
consumption
enhance
performance
materials,
thereby
providing
competitive
advantages
in
sustainability-oriented
sectors.
Moreover,
extracts
oils,
rich
bioactive
compounds
(essential
fatty
acids,
vitamins,
antioxidants,
cannabinoids),
demonstrated
therapeutic
potential,
reinforcing
role
development
food,
cosmetic,
pharmaceutical
products.
Additionally,
significantly
contributes
to
phytoremediation
by
absorbing
heavy
metals
contaminants
from
soil,
fibers
stand
out
their
durability
resistance,
being
valued
textile
industry
ecological
characteristics
performance.
Industrial
stands
high
versatility,
valuable
along
with
favorable
environmental
impact,
support
integration
wide
range
sectors,
opening
promising
perspectives
more
sustainable
responsible
future.
Language: Английский
The molecular anti-metastatic potential of CBD and THC from Lebanese Cannabis via apoptosis induction and alterations in autophagy
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Oct. 27, 2024
The
medicinal
plant
Cannabis
sativa
L.
(C.
sativa)
is
currently
being
extensively
studied
to
determine
the
full
extent
of
its
therapeutic
pharmacological
potential.
Δ9-tetrahydocannabinol
(THC)
and
cannabidiol
(CBD)
are
most
thoroughly
investigated
compounds.
We
aimed
explore
anticancer
activity
cannabinoids
mixture
isolated
from
Lebanese
C.
in
ratios
comparable
local
plant,
elucidate
mechanism
action
breast
cancer
cells
vitro.
Cells
were
subjected
cytotoxicity
assay,
cell
cycle
analysis,
Annexin
V/PI
dual
staining,
death
ELISA,
immunofluorescence,
addition
western
blot
analysis
apoptotic
autophagy
markers.
further
evaluated
anti-metastatic
effect
on
MDA-MB-231
using
scratch
wound-healing,
trans-well
migration
invasion
assays.
Our
results
revealed
promising
benefits
CBD/THC
inhibiting
growth
by
promoting
cellular
fragmentation,
phosphatidylserine
translocation
outer
membrane
leaflet
DNA
fragmentation
both
lines
while
motility
triple
negative
cells.
In
our
study,
was
found
exhibit
a
pro-apoptotic
via
activation
mitochondrial
pathway,
independent
ROS
production
also
suggesting
caspase-dependent
pathway.
Even
though
altered
upon
exposure
cannabinoid
mixture,
data
suggested
that
it
not
responsible
inducing
death.
conclusion,
study
demonstrates
CBD
THC
Language: Английский
Efficiency and safety of cannabinoid medical use: an analysis of discussions and observed trends on Instagram
Frontiers in Public Health,
Journal Year:
2024,
Volume and Issue:
12
Published: Dec. 4, 2024
Cannabis
and
its
derivatives
show
encouraging
therapeutic
effects
in
the
treatment
of
various
diseases.
However,
further
studies
are
needed
to
better
assess
their
efficacy
safety.
A
promising
base
for
research
field
medicine
additional
pharmacovigilance
is
social
networks,
which
experience
knowledge
exchanged
between
researchers,
doctors,
patients,
as
well
information
about
potential
risks
benefits
using
drugs
medical
purposes
disseminated.
The
aim
this
study
was
investigate
reported
efficiency
safety
use
cannabinoids
patients
posts
on
media
Instagram
analyze
observed
trends.
Language: Английский
Assessing the Potential Synergistic/Antagonistic Effects of Citrinin and Cannabidiol on SH-SY5Y, HepG2, HEK293 Cell Lines, and Human Lymphocytes
Toxins,
Journal Year:
2024,
Volume and Issue:
16(12), P. 534 - 534
Published: Dec. 11, 2024
The
increasing
use
of
Cannabis
sativa
products
for
medicinal,
dietary,
and
recreational
purposes
has
raised
concerns
about
mycotoxin
contamination
in
cannabis
hemp.
Mycotoxins
persist
these
products’
post-processing,
posing
health
risks
via
multiple
exposure
routes.
This
study
investigated
cytotoxic
genotoxic
interactions
between
cannabidiol
(CBD)
the
citrinin
(CIT)
using
human
cell
models:
SH-SY5Y,
HepG2,
HEK293,
peripheral
blood
lymphocytes.
IC50
values
membrane
disruption
were
initially
assessed,
followed
by
an
evaluation
genotoxicity
lymphocytes
Comet
Assay
Cytokinesis
Blocked
Micronucleus
Cytome
Assay.
Obtained
findings
demonstrate
that
cell-type
sensitivity
varied
across
treatments,
with
combined
CBD
CIT
exhibiting
distinct
interactions.
Lactate
dehydrogenase
(LDH)
release
remained
minimal,
suggesting
cytotoxicity
did
not
stem
from
but
likely
involved
intracellular
pathways.
In
lymphocytes,
alone
produced
negligible
cyto/genotoxic
effects
weak
antiproliferative
responses,
whereas
displayed
clear
toxic
impacts.
DNA
damage
indicates
may
induce
genome
instability
through
indirect
mechanisms
rather
than
direct
interaction,
evidence
potential
aneuploidic
CBMN
Cyt
Combined
led
to
a
reduction
CIT-induced
cytogenetic
damage,
CIT’s
interference
beneficial
properties
CBD.
These
results
provide
foundation
further
toxicological
assessments
highlight
necessity
standardized
monitoring
cannabis-derived
products.
Language: Английский
New Relevant Evidence in Cholangiocarcinoma Biology and Characterization
Cancers,
Journal Year:
2024,
Volume and Issue:
16(24), P. 4239 - 4239
Published: Dec. 19, 2024
Among
solid
tumors,
cholangiocarcinoma
(CCA)
emerges
as
one
of
the
most
difficult
to
eradicate.
The
silent
and
asymptomatic
nature
this
tumor,
particularly
in
its
early
stages,
well
high
heterogeneity
at
genomic,
epigenetic,
molecular
levels
delay
diagnosis,
significantly
compromising
efficacy
current
therapeutic
options
thus
contributing
a
dismal
prognosis.
Extensive
research
has
been
conducted
on
pathobiology
CCA,
recent
advances
have
made
classification
characterization
new
targets.
Both
targeted
therapy
immunotherapy
emerged
effective
safe
strategies
for
various
types
cancers,
demonstrating
potential
benefits
advanced
CCA.
Furthermore,
deeper
comprehension
cellular
components
tumor
microenvironment
(TME)
opened
up
possibilities
innovative
treatment
methods.
This
review
discusses
evidence
biology
highlighting
novel
possible
druggable
Language: Английский